This is why there are clinical tests being conducted with the aim of verifying the usefulness and safety of using selective HRH4 antagonists in allergic and autoimmune diseases, including asthma, rheumatoid arthritis, and atopic dermatitis. The gene discussed is HRH4; the disease is atopic eczema.